Kinfo
Moolec Science SA logo

Moolec Science SA

MLECNASDAQHealthcare·US · USD
$1.71
-0.09 (-5.06%)
Prices as of October 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap1.24M USD
Enterprise value247.35M USD
Trailing P/E-0.01
Forward P/E-9.17
PEG ratio-0.00
Price / sales0.00
Price / book3.15
Profitability
Gross margin-25.52%
Operating margin-39.54%
Profit margin37.69%
Return on assets-22.61%
Return on equity55.85%
Income (TTM)
Revenue333.61M USD
Gross profit125.74M USD
EBITDA0.00 USD
Net income18.90M USD
Diluted EPS-$199.02
Rev. growth (YoY)69.75%
Balance sheet
Total cash1.04M USD
Total debt66.48M USD
Debt / equity4.38
Current ratio0.15
Book value / share$0.70
Cash flow (TTM)
Operating cash flow3.64M USD
Levered free cash flow-46.28M USD
Shares & price
Shares outstanding725.57K
Float0.00
Held by institutions0.07%
Beta0.00
50-day MA$6.35
200-day MA$7.42
52-week high$23.22
52-week low$1.64
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-041.321.35+2.27%2025-11-180.250.33+32.00%2025-04-16-0.60-0.60+0.00%2025-01-31-0.70-0.50+28.57%2024-10-30-0.60-0.60+0.00%
About Moolec Science SA

Moolec Science SA is a science-based food ingredient company focused on developing functional ingredients through molecular farming and precision fermentation. Moolec Science SA creates ingredients for food, pet food, animal feed, and dietary supplements by engineering crops such as soy and safflower, as well as using microbial systems, to produce animal-like proteins, nutritional oils, and other bioactive compounds. Its current product portfolio includes textured soy proteins, safflower-derived oil, meat replacement ingredients, and protein-based formulations designed for use in plant-based and hybrid food applications. The company operates an integrated platform that combines research and development, manufacturing, and regulatory capabilities to support product validation and commercialization across multiple markets. Moolec Science SA serves the alternative protein and specialty ingredients segments of the food industry, where it aims to provide ingredients with animal-like functionality while using plant-based production systems.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Gaston Paladini M.B.A.
Employees
52
Headquarters
Grand Cayman, Cayman Islands

Frequently asked questions about Moolec Science SA